Effects of Medical and Surgical Weight Loss on Metabolism (BOS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2008 by Garvan Institute of Medical Research.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Garvan Institute of Medical Research
ClinicalTrials.gov Identifier:
NCT00592735
First received: January 1, 2008
Last updated: January 11, 2008
Last verified: January 2008

January 1, 2008
January 11, 2008
May 2007
December 2008   (final data collection date for primary outcome measure)
weight loss [ Time Frame: 6 months ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00592735 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Effects of Medical and Surgical Weight Loss on Metabolism
The Role of Adipocyte-Derived Inflammatory Cytokines in the Pathogenesis of Diabetes, Dyslipidaemia, Atherosclerosis and Gastro-Oesophageal Reflux Disease: the Effects of Medical and Surgical Weight Loss

This study will follow ,morbidly obese subjects as they undertake weight loss before and after laparoscopic gastric banding, examining markers of glucose and lipid metabolism, adipokines and measures of body fat.

Not Provided
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

serum, tissue

Non-Probability Sample

morbidly obese subjects with type 2 diabetes or metabolic syndrome

  • Type 2 Diabetes
  • Obesity
Procedure: laparoscopic gastric banding
standard surgical procedure
1
Intervention: Procedure: laparoscopic gastric banding
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
20
December 2008
December 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • morbidly obese subjects with type 2 diabetes or metabolic syndrome
  • age <70

Exclusion Criteria:

  • contra-indications to bariatric surgery
Both
18 Years to 70 Years
No
Contact: Katherine Samaras, MBBS, FRACP, PhD +61-2-9295-8312 k.samaras@garvan.org.au
Australia
 
NCT00592735
SVH H06/151, SVH H06/151
No
Katherine Samaras, Garvan Institute of Medical Research
Garvan Institute of Medical Research
Not Provided
Not Provided
Garvan Institute of Medical Research
January 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP